文献速递乳腺外科

无细胞真皮基质辅助一步法乳房重建术后并发症预测因素:多中心随机试验分析

Predictors of complications after direct-to-implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial.
PubMed 文献 · Br J Surg · 2018-04-16

本研究基于BRIOS多中心随机试验数据,纳入59例(91侧乳房)接受无细胞真皮基质辅助一步法乳房重建的患者,采用logistic回归分析并发症预测因素。结果显示,乳房切除标本重量与并发症、再手术及假体取出均相关;年轻患者和接受辅助化疗者更常需再手术。结论认为乳房大小是该术式最重要的并发症预测因素,建议优先用于中小体积乳房患者。

要点

  • 乳房切除标本重量是并发症、再手术及假体取出的独立预测因素。
  • 年轻患者及接受辅助化疗者再手术风险更高。
  • 辅助放疗与并发症及假体取出呈非显著升高趋势。

核心结论

  • 乳房大小(以乳房切除标本重量衡量)是无细胞真皮基质辅助一步法乳房重建术后并发症的最重要预测因素。

研究设计与样本

  • 基于多中心随机试验BRIOS的数据,纳入所有接受无细胞真皮基质辅助一步法乳房重建的患者,共59例(91侧乳房)。
  • 采用logistic回归分析识别术后并发症的预测因素。

主要发现

  • 27例患者(35侧乳房)发生手术并发症。
  • 29侧乳房(32%)接受再手术,其中22侧(24%)取出假体。

临床怎么用

  • 该技术宜优先用于中小体积乳房的患者。
  • 对乳房较大、年轻或需辅助化疗的患者,应充分评估并发症及再手术风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the multicentre randomized trial BRIOS (Breast Reconstruction In One Stage), direct-to-implant (DTI) breast reconstruction with an acellular dermal matrix (ADM) was associated with a markedly higher postoperative complication rate compared with two-stage tissue expander/implant breast reconstruction. This study aimed to identify factors that contribute to the occurrence of complications after DTI ADM-assisted breast reconstruction. METHODS: Data were obtained from the BRIOS study, including all patients treated with DTI ADM-assisted breast reconstruction. Logistic regression analyses were performed to identify factors predictive of postoperative complications. RESULTS: Fifty-nine patients (91 breasts) were included, of whom 27 (35 breasts) developed a surgical complication. Reoperations were performed in 29 breasts (32 per cent), with prosthesis removal in 22 (24 per cent). In multivariable analyses, mastectomy weight was associated with complications (odds ratio (OR) 1·94, 95 per cent c.i. 1·33 to 2·83), reoperations (OR 1·70, 1·12 to 2·59) and removal of the implant (OR 1·55, 1·11 to 2·17). Younger patients (OR 1·07, 1·01 to 1·13) and those who received adjuvant chemotherapy (OR 4·83, 1·15 to 20·24) more frequently required reoperation. In univariable analyses, adjuvant radiotherapy showed a trend towards more complications (OR 7·23, 0·75 to 69·95) and removal of the implant (OR 5·12, 0·76 to 34·44), without reaching statistical significance. CONCLUSION: Breast size appeared to be the most significant predictor of complications in DTI ADM-assisted breast reconstruction. The technique should preferably be performed in patients with small to moderate sized breasts. Registration number: NTR5446 ( http://www.trialregister.nl).

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Negenborn VL, Dikmans REG, Bouman MB, et al. Predictors of complications after direct-to-implant breast reconstruction with an acellular dermal matrix from a multicentre randomized clinical trial. Br J Surg. 2018. PMID: 29663320. doi:10.1002/bjs.10865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。